(Total Views: 513)
Posted On: 06/23/2022 10:10:03 AM
Post# of 145247
So you say this is common practice that a company (not DSMB or ANVISA) halt a trial of a drug with splendid safety profile, before any conclusions were done? The made the trial halt before it was even clear if the patients were on placebo or treatment arm, if I remember correctly. I cannot believe that is common practice!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)